Search Result "aml antigens"


Review Article

Novel Antigen Targets for Immunotherapy of Acute Myeloid Leukemia

Journal: Current Drug Targets
Volume: 18 Issue: 3 Year: 2017 Page: 296-303
Author(s): Meghali Goswami,Christopher S. Hourigan

Review Article

The Role of DNA Repair Pathways in AML Chemosensitivity

Journal: Current Drug Targets
Volume: 19 Issue: 1 Year: 2018 Page: 1205-1219
Author(s): Elizabeth A. Pearsall,Lisa F. Lincz,Kathryn A. Skelding

Nontoxic-dose of Deguelin Induce NPMc+ AML Cell Differentiation by Selectively Targeting Mt NPM1/SIRT1 Instead of HDAC1/3

Journal: Current Cancer Drug Targets
Volume: 14 Issue: 8 Year: 2014 Page: 685-699
Author(s): You P. Wang,Sha Yi,Lu Wen,Ben P. Zhang,Zichu Zhao,Jing Y. Hu,Fei Zhao,Jing He,Jun Fang,Chun Zhang,Guohui Cui,Yan Chen

Review Article

Immunomodulatory Drugs: IMiDs in Acute Myeloid Leukemia (AML)

Journal: Current Drug Targets
Volume: 18 Issue: 3 Year: 2017 Page: 304-314
Author(s): Joshua F. Zeidner,Matthew C. Foster

Proteomics in Acute Myelogenous Leukaemia (AML): Methodological Strategies and Identification of Protein Targets for Novel Antileukaemic Therapy

Journal: Current Drug Targets
Volume: 6 Issue: 6 Year: 2005 Page: 631-646
Author(s): G. Sjoholt, N. Anensen, L. Wergeland, E. Mc Cormack, O. Bruserud, B. T. Gjertsen

Treatment of Acute Leukaemias with Monoclonal Antibodies: Current Status and Future Prospects

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 4 Issue: 1 Year: 2006 Page: 33-52
Author(s): G. Leone, S. Sica, M. T. Voso, S. Rutella, L. Pagano

The Hsp32 Inhibitors SMA-ZnPP and PEG-ZnPP Exert Major Growth-Inhibitory Effects on CD34+/CD38+ and CD34+/CD38- AML Progenitor Cells

Journal: Current Cancer Drug Targets
Volume: 12 Issue: 1 Year: 2012 Page: 51-63
Author(s): H. Herrmann, M. Kneidinger, S. Cerny-Reiterer, T. Rulicke, M. Willmann, K. V. Gleixner, K. Blatt, G. Hormann, B. Peter, P. Samorapoompichit, W. Pickl, G. Y. Bharate, M. Mayerhofer, W. R. Sperr, H. Maeda, P. Valent

The Phosphoinositide 3-Kinase (PI3K)/AKT Signaling Pathway as a Therapeutic Target for the Treatment of Human Acute Myeloid Leukemia (AML)

Journal: Current Signal Transduction Therapy
Volume: 2 Issue: 3 Year: 2007 Page: 246-256
Author(s): Alberto M. Martelli, Giovanna Tabellini, Roberta Bortul, Maria Nyakern, Pier Luigi Tazzari, Camilla Evangelisti, Lucio Cocco

Immunotherapy of Acute Myeloid Leukemia

Journal: Current Pharmaceutical Biotechnology
Volume: 2 Issue: 3 Year: 2001 Page: 209-215
Author(s): Arthur E. Frankel, Maria R. Baer, Donna E. Hogge, Robert K. Stuart

Mapping the High Throughput SEREX Technology Screening for Novel Tumor Antigens

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 15 Issue: 3 Year: 2012 Page: 202-215
Author(s): Shengtao Zhou, Tao Yi, Boya Zhang, Fuqiang Huang, Huiqiong Huang, Jing Tang, Xia Zhao

Previous   Next

Go To   Results 1 - 1 of 782

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy